ghk-cu peptide clinical studies Research Guide: Copper Overview and Laboratory Research GHK-Cu – 50mg – Peptidic.

THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans

The highest risk would be if you were injecting the substance

Mol Cancer 17(1):8585

Gut Health Evaluation: To understand the role of your microbiome in your overall health